| Item Type | Name |
|
Concept
|
Coronary Artery Bypass, Off-Pump
|
|
Concept
|
Coronary Artery Bypass
|
|
Academic Article
|
Myocardial ischemia and infarction.
|
|
Academic Article
|
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
|
Academic Article
|
Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.
|
|
Academic Article
|
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
|
|
Academic Article
|
Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.
|
|
Academic Article
|
The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.
|
|
Academic Article
|
Letter regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study".
|
|
Academic Article
|
Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.
|
|
Academic Article
|
Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
|
|
Academic Article
|
Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
|
|
Academic Article
|
Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes.
|
|
Academic Article
|
Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts.
|
|
Academic Article
|
Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
|
|
Academic Article
|
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
|
|
Academic Article
|
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
|
|
Academic Article
|
Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative).
|
|
Academic Article
|
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
|
|
Academic Article
|
Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting.
|
|
Academic Article
|
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes.
|
|
Academic Article
|
Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV.
|
|
Academic Article
|
Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
|
|
Academic Article
|
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale.
|
|
Academic Article
|
Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.
|
|
Academic Article
|
Outcomes of second revascularization procedures after stent implantation.
|
|
Academic Article
|
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV).
|
|
Academic Article
|
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery.
|
|
Academic Article
|
Early versus delayed, provisional eptifibatide in acute coronary syndromes.
|
|
Academic Article
|
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery.
|
|
Academic Article
|
Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial.
|
|
Academic Article
|
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
|
|
Academic Article
|
Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting.
|
|
Academic Article
|
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.
|
|
Academic Article
|
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.
|
|
Academic Article
|
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
|
|
Academic Article
|
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.
|
|
Academic Article
|
Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery.
|
|
Academic Article
|
Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial.
|
|
Academic Article
|
Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
|
|
Academic Article
|
Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.
|
|
Academic Article
|
Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting.
|
|
Academic Article
|
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).
|
|
Academic Article
|
Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.
|
|
Academic Article
|
Predictors of contemporary coronary artery bypass grafting outcomes.
|
|
Academic Article
|
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial.
|
|
Academic Article
|
Selecting revascularization strategies in patients with coronary disease.
|
|
Academic Article
|
Coronary Artery Bypass Surgery Is Not Underutilized!
|
|
Academic Article
|
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.
|
|
Academic Article
|
Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial".
|
|
Academic Article
|
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
|
|
Academic Article
|
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
|
|
Academic Article
|
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
|
|
Academic Article
|
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy).
|
|
Academic Article
|
Clinical decisions. Management of stable coronary disease.
|
|
Academic Article
|
Calculating risks and benefits to help guide revascularization decisions: turning all available data into useful information.
|
|
Academic Article
|
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.
|
|
Academic Article
|
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
|